{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T02:42:20Z","timestamp":1791513740600,"version":"4.3.4"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T00:00:00Z","timestamp":1785369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T00:00:00Z","timestamp":1785369600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"DOI":"10.1038\/s41401-026-01878-7","type":"journal-article","created":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T08:13:30Z","timestamp":1785399210000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Macrophage FOLR2 drives liver fibrosis via intercellular engagement of TGF\u03b2RII"],"prefix":"10.1038","author":[{"given":"Man-man","family":"Yuan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing-feng","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-lin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai-qi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng-lan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian-chi","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi-hua","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing-xin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,30]]},"reference":[{"key":"1878_CR1","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1038\/s41392-022-01070-3","volume":"7","author":"M Zhao","year":"2022","unstructured":"Zhao M, Wang L, Wang M, Zhou S, Lu Y, Cui H, et al. Targeting fibrosis, mechanisms and cilinical trials. Signal Transduct Target Ther. 2022;7:206.","journal-title":"Signal Transduct Target Ther"},{"key":"1878_CR2","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.biomaterials.2019.03.025","volume":"206","author":"C Ergen","year":"2019","unstructured":"Ergen C, Niemietz PM, Heymann F, Baues M, Gremse F, Pola R, et al. Liver fibrosis affects the targeting properties of drug delivery systems to macrophage subsets in vivo. Biomaterials. 2019;206:49\u201360.","journal-title":"Biomaterials"},{"key":"1878_CR3","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jhep.2018.09.014","volume":"70","author":"SK Asrani","year":"2019","unstructured":"Asrani SK, Devarbhavi H, Eaton J, Kamath PS. Burden of liver diseases in the world. J Hepatol. 2019;70:151\u201371.","journal-title":"J Hepatol"},{"key":"1878_CR4","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1007\/s40265-024-02045-0","volume":"84","author":"SJ Keam","year":"2024","unstructured":"Keam SJ. Resmetirom: first approval. Drugs. 2024;84:729\u201335.","journal-title":"Drugs"},{"key":"1878_CR5","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1056\/NEJMoa2309000","volume":"390","author":"SA Harrison","year":"2024","unstructured":"Harrison SA, Bedossa P, Guy CD, Schattenberg JM, Loomba R, Taub R, et al. A phase 3, randomized, controlled trial of resmetirom in NASH with liver fibrosis. N Engl J Med. 2024;390:497\u2013509.","journal-title":"N Engl J Med"},{"key":"1878_CR6","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1016\/j.cmet.2024.05.003","volume":"36","author":"P Horn","year":"2024","unstructured":"Horn P, Tacke F. Metabolic reprogramming in liver fibrosis. Cell Metab. 2024;36:1439\u201355.","journal-title":"Cell Metab"},{"key":"1878_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.730176","volume":"9","author":"Z Tan","year":"2021","unstructured":"Tan Z, Sun H, Xue T, Gan C, Liu H, Xie Y, et al. Liver fibrosis: therapeutic targets and advances in drug therapy. Front Cell Dev Biol. 2021;9:730176.","journal-title":"Front Cell Dev Biol"},{"key":"1878_CR8","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41575-020-00372-7","volume":"18","author":"T Kisseleva","year":"2021","unstructured":"Kisseleva T, Brenner D. Molecular and cellular mechanisms of liver fibrosis and its regression. Nat Rev Gastroenterol Hepatol. 2021;18:151\u201366.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1878_CR9","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1053\/j.gastro.2019.11.311","volume":"158","author":"RF Schwabe","year":"2020","unstructured":"Schwabe RF, Tabas I, Pajvani UB. Mechanisms of fibrosis development in nonalcoholic steatohepatitis. Gastroenterology. 2020;158:1913\u201328.","journal-title":"Gastroenterology"},{"key":"1878_CR10","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1016\/j.jhep.2017.02.026","volume":"66","author":"F Tacke","year":"2017","unstructured":"Tacke F. Targeting hepatic macrophages to treat liver diseases. J Hepatol. 2017;66:1300\u201312.","journal-title":"J Hepatol"},{"key":"1878_CR11","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1038\/s41423-025-01298-3","volume":"22","author":"Y Nusse","year":"2025","unstructured":"Nusse Y, Kubes P. Liver macrophages: development, dynamics, and functions. Cell Mol Immunol. 2025;22:1178\u201389.","journal-title":"Cell Mol Immunol"},{"key":"1878_CR12","doi-asserted-by":"publisher","first-page":"E3186","DOI":"10.1073\/pnas.1119964109","volume":"109","author":"P Ramachandran","year":"2012","unstructured":"Ramachandran P, Pellicoro A, Vernon MA, Boulter L, Aucott RL, Ali A, et al. Differential Ly-6C expression identifies the recruited macrophage phenotype, which orchestrates the regression of murine liver fibrosis. Proc Natl Acad Sci USA. 2012;109:E3186\u201395.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1878_CR13","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1002\/hep.26783","volume":"59","author":"C Baeck","year":"2014","unstructured":"Baeck C, Wei X, Bartneck M, Fech V, Heymann F, Gassler N, et al. Pharmacological inhibition of the chemokine C-C motif chemokine ligand 2 (monocyte chemoattractant protein 1) accelerates liver fibrosis regression by suppressing Ly-6C+ macrophage infiltration in mice. Hepatology. 2014;59:1060\u201372.","journal-title":"Hepatology"},{"key":"1878_CR14","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s13046-019-1123-1","volume":"38","author":"B Frigerio","year":"2019","unstructured":"Frigerio B, Bizzoni C, Jansen G, Leamon CP, Peters GJ, Low PS, et al. Folate receptors and transporters: biological role and diagnostic\/therapeutic targets in cancer and other diseases. J Exp Clin Cancer Res. 2019;38:125.","journal-title":"J Exp Clin Cancer Res"},{"key":"1878_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1638907","volume":"16","author":"F Zhang","year":"2025","unstructured":"Zhang F, Al-Amin MY, Utturkar S, Jiang R, Cresswell G, Alfar R, et al. Folate receptor \u03b2 performs an immune checkpoint function in activated macrophages. Front Immunol. 2025;16:1638907.","journal-title":"Front Immunol"},{"key":"1878_CR16","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.4049\/jimmunol.1501878","volume":"197","author":"C Machacek","year":"2016","unstructured":"Machacek C, Supper V, Leksa V, Mitulovic G, Spittler A, Drbal K, et al. Folate receptor \u03b2 regulates integrin CD11b\/CD18 adhesion of a macrophage subset to collagen. J Immunol. 2016;197:2229\u201338.","journal-title":"J Immunol"},{"key":"1878_CR17","doi-asserted-by":"publisher","first-page":"8064","DOI":"10.12659\/MSM.911384","volume":"24","author":"X Xu","year":"2018","unstructured":"Xu X, Jiang J, Yao L, Ji B. Silencing the FOLR2 gene inhibits cell proliferation and increases apoptosis in the NCI-H1650 non-small cell lung cancer cell line via inhibition of AKT\/mammalian target of rapamycin (mTOR)\/ribosomal protein s6 kinase 1 (S6K1) signaling. Med Sci Monit. 2018;24:8064\u201373.","journal-title":"Med Sci Monit"},{"key":"1878_CR18","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1002\/hep.32782","volume":"77","author":"S Zhang","year":"2023","unstructured":"Zhang S, Wan D, Zhu M, Wang G, Zhang X, Huang N, et al. CD11b+ CD43hi Ly6Clo splenocyte-derived macrophages exacerbate liver fibrosis via spleen-liver axis. Hepatology. 2023;77:1612\u201329.","journal-title":"Hepatology"},{"key":"1878_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms13498","volume":"7","author":"X Wu","year":"2016","unstructured":"Wu X, Wu X, Ma Y, Shao F, Tan Y, Tan T, et al. CUG-binding protein 1 regulates HSC activation and liver fibrogenesis. Nat Commun. 2016;7:13498.","journal-title":"Nat Commun"},{"key":"1878_CR20","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/978-1-4939-7163-3_16","volume":"1639","author":"M Aparicio-Vergara","year":"2017","unstructured":"Aparicio-Vergara M, Tencerova M, Morgantini C, Barreby E, Aouadi M. Isolation of Kupffer cells and hepatocytes from a single mouse liver. Methods Mol Biol. 2017;1639:161\u201371.","journal-title":"Methods Mol Biol"},{"key":"1878_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-55325-4","volume":"16","author":"BR Watson","year":"2025","unstructured":"Watson BR, Paul B, Rahman RU, Amir-Zilberstein L, Segerstolpe \u00c5, Epstein ET, et al. Spatial transcriptomics of healthy and fibrotic human liver at single-cell resolution. Nat Commun. 2025;16:319.","journal-title":"Nat Commun"},{"key":"1878_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-017-1382-0","volume":"19","author":"FA Wolf","year":"2018","unstructured":"Wolf FA, Angerer P, Theis FJ. SCANPY: large-scale single-cell gene expression data analysis. Genome Biol. 2018;19:15.","journal-title":"Genome Biol"},{"key":"1878_CR23","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1093\/bioinformatics\/btz625","volume":"36","author":"K Pola\u0144ski","year":"2020","unstructured":"Pola\u0144ski K, Young MD, Miao Z, Meyer KB, Teichmann SA, Park JE. BBKNN: fast batch alignment of single cell transcriptomes. Bioinformatics. 2020;36:964\u20135.","journal-title":"Bioinformatics"},{"key":"1878_CR24","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1038\/s41587-023-01657-3","volume":"41","author":"S Mages","year":"2023","unstructured":"Mages S, Moriel N, Avraham-Davidi I, Murray E, Watter J, Chen F, et al. TACCO unifies annotation transfer and decomposition of cell identities for single-cell and spatial omics. Nat Biotechnol. 2023;41:1465\u201373.","journal-title":"Nat Biotechnol"},{"key":"1878_CR25","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1016\/j.immuni.2018.10.011","volume":"49","author":"DE Sanin","year":"2018","unstructured":"Sanin DE, Matsushita M, Klein Geltink RI, Grzes KM, van Teijlingen Bakker N, Corrado M, et al. Mitochondrial membrane potential regulates nuclear gene expression in macrophages exposed to prostaglandin E2. Immunity. 2018;49:1021\u201333.e6.","journal-title":"Immunity"},{"key":"1878_CR26","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.add8945","volume":"8","author":"T Fabre","year":"2023","unstructured":"Fabre T, Barron AMS, Christensen SM, Asano S, Bound K, Lech MP, et al. Identification of a broadly fibrogenic macrophage subset induced by type 3 inflammation. Sci Immunol. 2023;8:eadd8945.","journal-title":"Sci Immunol"},{"key":"1878_CR27","doi-asserted-by":"publisher","first-page":"L507","DOI":"10.1152\/ajplung.00263.2022","volume":"324","author":"CM Novak","year":"2023","unstructured":"Novak CM, Sethuraman S, Luikart KL, Reader BF, Wheat JS, Whitson B, et al. Alveolar macrophages drive lung fibroblast function in cocultures of IPF and normal patient samples. Am J Physiol Lung Cell Mol Physiol. 2023;324:L507\u2013l20.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"1878_CR28","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/nprot.2015.017","volume":"10","author":"I Mederacke","year":"2015","unstructured":"Mederacke I, Dapito DH, Aff\u00f2 S, Uchinami H, Schwabe RF. High-yield and high-purity isolation of hepatic stellate cells from normal and fibrotic mouse livers. Nat Protoc. 2015;10:305\u201315.","journal-title":"Nat Protoc"},{"key":"1878_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.108626","volume":"34","author":"S Daemen","year":"2021","unstructured":"Daemen S, Gainullina A, Kalugotla G, He L, Chan MM, Beals JW, et al. Dynamic shifts in the composition of resident and recruited macrophages influence tissue remodeling in NASH. Cell Rep. 2021;34:108626.","journal-title":"Cell Rep"},{"key":"1878_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/srep43446","volume":"7","author":"M Wang","year":"2017","unstructured":"Wang M, Gong Q, Zhang J, Chen L, Zhang Z, Lu L, et al. Characterization of gene expression profiles in HBV-related liver fibrosis patients and identification of ITGBL1 as a key regulator of fibrogenesis. Sci Rep. 2017;7:43446.","journal-title":"Sci Rep"},{"key":"1878_CR31","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1053\/j.gastro.2013.01.021","volume":"144","author":"Y Hoshida","year":"2013","unstructured":"Hoshida Y, Villanueva A, Sangiovanni A, Sole M, Hur C, Andersson KL, et al. Prognostic gene expression signature for patients with hepatitis C-related early-stage cirrhosis. Gastroenterology. 2013;144:1024\u201330.","journal-title":"Gastroenterology"},{"key":"1878_CR32","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1056\/NEJMoa0804525","volume":"359","author":"Y Hoshida","year":"2008","unstructured":"Hoshida Y, Villanueva A, Kobayashi M, Peix J, Chiang DY, Camargo A, et al. Gene expression in fixed tissues and outcome in hepatocellular carcinoma. N Engl J Med. 2008;359:1995\u20132004.","journal-title":"N Engl J Med"},{"key":"1878_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2021.100278","volume":"3","author":"VL Payen","year":"2021","unstructured":"Payen VL, Lavergne A, Alevra Sarika N, Colonval M, Karim L, Deckers M, et al. Single-cell RNA sequencing of human liver reveals hepatic stellate cell heterogeneity. JHEP Rep. 2021;3:100278.","journal-title":"JHEP Rep"},{"key":"1878_CR34","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/j.molcel.2019.07.028","volume":"75","author":"X Xiong","year":"2019","unstructured":"Xiong X, Kuang H, Ansari S, Liu T, Gong J, Wang S, et al. Landscape of intercellular crosstalk in healthy and NASH liver revealed by single-cell secretome gene analysis. Mol Cell. 2019;75:644\u201360.e5.","journal-title":"Mol Cell"},{"key":"1878_CR35","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41423-020-00558-8","volume":"18","author":"Y Wen","year":"2021","unstructured":"Wen Y, Lambrecht J, Ju C, Tacke F. Hepatic macrophages in liver homeostasis and diseases-diversity, plasticity and therapeutic opportunities. Cell Mol Immunol. 2021;18:45\u201356.","journal-title":"Cell Mol Immunol"},{"key":"1878_CR36","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.1080\/10717544.2021.1976310","volume":"28","author":"J Li","year":"2021","unstructured":"Li J, Feng T, Yang W, Xu Y, Wang S, Cai H, et al. Rational formulation engineering of fraxinellone utilizing 6-O-\u03b1-D-maltosyl-\u03b2-cyclodextrin for enhanced oral bioavailability and hepatic fibrosis therapy. Drug Deliv. 2021;28:1890\u2013902.","journal-title":"Drug Deliv"},{"key":"1878_CR37","doi-asserted-by":"publisher","DOI":"10.1177\/19476035221081469","volume":"13","author":"K Warmink","year":"2022","unstructured":"Warmink K, Siebelt M, Low PS, Riemers FM, Wang B, Plomp SGM, et al. Folate receptor expression by human monocyte-derived macrophage subtypes and effects of corticosteroids. Cartilage. 2022;13:19476035221081469.","journal-title":"Cartilage"},{"key":"1878_CR38","doi-asserted-by":"crossref","unstructured":"Roy AG, Robinson JM, Sharma P, Rodriguez-Garcia A, Poussin MA, Nickerson-Nutter C, et al. Folate receptor beta as a direct and indirect target for antibody-based cancer immunotherapy. Int J Mol Sci. 2021;22.","DOI":"10.3390\/ijms22115572"},{"key":"1878_CR39","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1007\/s13346-018-0589-2","volume":"9","author":"D Chandrupatla","year":"2019","unstructured":"Chandrupatla D, Molthoff CFM, Lammertsma AA, van der Laken CJ, Jansen G. The folate receptor \u03b2 as a macrophage-mediated imaging and therapeutic target in rheumatoid arthritis. Drug Deliv Transl Res. 2019;9:366\u201378.","journal-title":"Drug Deliv Transl Res"},{"key":"1878_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-44886-z","volume":"15","author":"C Cohen","year":"2024","unstructured":"Cohen C, Mhaidly R, Croizer H, Kieffer Y, Leclere R, Vincent-Salomon A, et al. WNT-dependent interaction between inflammatory fibroblasts and FOLR2+ macrophages promotes fibrosis in chronic kidney disease. Nat Commun. 2024;15:743.","journal-title":"Nat Commun"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01878-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01878-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01878-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T21:02:31Z","timestamp":1785445351000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01878-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,30]]},"references-count":40,"alternative-id":["1878"],"URL":"https:\/\/doi.org\/10.1038\/s41401-026-01878-7","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,30]]},"assertion":[{"value":"26 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}